These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 19062041

  • 1. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
    Kaji T, Tanaka H, Redstone H, Wallace LE, Holst JJ, Sigalet DL.
    J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
    [Abstract] [Full Text] [Related]

  • 2. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
    Martin GR, Wallace LE, Sigalet DL.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
    [Abstract] [Full Text] [Related]

  • 3. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.
    Kaji T, Tanaka H, Holst JJ, Redstone H, Wallace L, de Heuval E, Sigalet DL.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):138-45. PubMed ID: 18762180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N, Gu LH, Gu L, Openo KP, Jones DP, Ziegler TR.
    JPEN J Parenter Enteral Nutr; 2004 Oct 31; 28(6):399-409. PubMed ID: 15568286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide-2 protects against TPN-induced intestinal hexose malabsorption in enterally refed piglets.
    Cottrell JJ, Stoll B, Buddington RK, Stephens JE, Cui L, Chang X, Burrin DG.
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb 31; 290(2):G293-300. PubMed ID: 16166344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nutritional effects of the serial transverse enteroplasty procedure in experimental short bowel syndrome.
    Kaji T, Tanaka H, Wallace LE, Kravarusic D, Holst J, Sigalet DL.
    J Pediatr Surg; 2009 Aug 31; 44(8):1552-9. PubMed ID: 19635304
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection.
    Topstad D, Martin G, Sigalet D.
    J Pediatr Surg; 2001 May 31; 36(5):750-4. PubMed ID: 11329581
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.
    Liu X, Nelson DW, Holst JJ, Ney DM.
    Am J Clin Nutr; 2006 Nov 31; 84(5):1142-50. PubMed ID: 17093168
    [Abstract] [Full Text] [Related]

  • 13. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2.
    Chance WT, Sheriff S, Foley-Nelson T, Thomas I, Balasubramaniam A.
    Nutr Cancer; 2000 Nov 31; 37(2):215-22. PubMed ID: 11142096
    [Abstract] [Full Text] [Related]

  • 14. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
    Tavakkolizadeh A, Shen R, Abraham P, Kormi N, Seifert P, Edelman ER, Jacobs DO, Zinner MJ, Ashley SW, Whang EE.
    J Surg Res; 2000 Jun 01; 91(1):77-82. PubMed ID: 10816354
    [Abstract] [Full Text] [Related]

  • 15. [Administration of growth hormone enhances the intestinal adaptive response after resection of small intestine in rats].
    Gómez de Segura IA, Aguilera MJ, Codesal J, De Miguel E.
    Rev Esp Enferm Dig; 1995 Apr 01; 87(4):288-93. PubMed ID: 7794635
    [Abstract] [Full Text] [Related]

  • 16. [Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome].
    Wu GH, Chen J, Li H, Wu ZH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep 01; 9(5):441-4. PubMed ID: 17043970
    [Abstract] [Full Text] [Related]

  • 17. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
    Yano K, Kaji T, Onishi S, Machigashira S, Nagai T, Harumatsu T, Yamada K, Yamada W, Muto M, Nakame K, Mukai M, Ieiri S.
    Pediatr Surg Int; 2019 Dec 01; 35(12):1345-1351. PubMed ID: 31555865
    [Abstract] [Full Text] [Related]

  • 18. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
    Martin GR, Wallace LE, Hartmann B, Holst JJ, Demchyshyn L, Toney K, Sigalet DL.
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar 01; 288(3):G431-8. PubMed ID: 15388486
    [Abstract] [Full Text] [Related]

  • 19. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
    Anini Y, Izzo A, Oudit GY, Backx PH, Brubaker PL.
    Am J Physiol Endocrinol Metab; 2007 Jun 01; 292(6):E1599-606. PubMed ID: 17284578
    [Abstract] [Full Text] [Related]

  • 20. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
    Koopmann MC, Nelson DW, Murali SG, Liu X, Brownfield MS, Holst JJ, Ney DM.
    JPEN J Parenter Enteral Nutr; 2008 Jun 01; 32(3):254-65. PubMed ID: 18443137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.